GlassScriptPhysician profile
David J Henderson
NPI 1417933284
$2,011.06
in general payments reported to CMS, 2019-2025
29 companies · $170 in 2025
The $170 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $255 · 2021: $407 · 2022: $336 · 2023: $274 · 2024: $124 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $568.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $237.20 | 2019-2023 | |
| Boston Scientific Corporation | $228.28 | 2020-2025 | Lynx System, Lumenis Pulse 120h |
| Abbvie INC. | $211.27 | 2019-2024 | |
| Allergan, INC. | $206.14 | 2019-2022 | |
| 180 Medical, INC. | $152.07 | 2019-2023 | |
| Janssen Biotech, INC. | $103.69 | 2019-2025 | Erleada |
| Antares Pharma, INC. | $100.78 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $93.96 | 2021-2025 | Prolaris |
| Ethicon US, LLC | $78.37 | 2019-2025 | Enseal |
| Amgen INC. | $74.82 | 2019 | |
| Myovant Sciences INC. | $73.87 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.73 | 2021-2022 | |
| Procept Biorobotics Corporation | $48.00 | 2021-2025 | |
| Coloplast Corp | $43.28 | 2022-2023 | Speedicath |
| Rochester Medical Corporation | $39.25 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $36.29 | 2023 | |
| Sumitomo Pharma America, INC. | $34.82 | 2023 | Gemtesa, Orgovyx |
| Teleflex LLC | $30.82 | 2019-2022 | |
| Cure Medical LLC | $27.43 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $20.58 | 2020 | |
| Dentsply Ih INC. | $16.90 | 2019 | |
| Srs Medical Systems, INC. | $15.75 | 2021 | |
| Endo Pharmaceuticals INC. | $14.67 | 2020 | |
| Olympus America INC. | $13.63 | 2025 | Olympus |
| Bard Access Systems, INC. | $12.69 | 2019 | |
| Paratek Pharmaceuticals, INC. | $12.67 | 2022 | |
| Therapeuticsmd, INC. | $12.50 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 | |
| Travere Therapeutics, INC. | $8.00 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Henderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.